Artificial Light at Night Increases Breast Cancer Risk

More breast cancer cases occur in high-light urban areas

By Heather Wright, ND, FABNO, and Jacob Schor, ND, FABNO

This article is part of the 2017 Women's Health Special Issue. Read the full issue or download it here. 

Reference

Portnov BA, Stevens RG, Samociuk H, Wakefield D, Gregorio DI. Light at night and breast cancer incidence in Connecticut: An ecological study of age group effects. Sci Total Environ. 2016;572:1020-1024.

Design

Observational study

Study Objective

This study tested the prediction that women living in communities with high nighttime outdoor light levels have higher breast cancer incidence rates. Breast cancer rates obtained from the tumor registry were linked to a spatial map using census data. This information was compared to data on light exposure at night obtained from satellite photos. To account for lag between exposure and breast cancer diagnosis, the study used a 10-year latency period, comparing years 2005-2009 data on breast cancer incidence with light at night data from 1996/97.

Participants

The whole female population of the state of Connecticut. Breast cancer data from the Connecticut Tumor Registry from 2005 to 2009 was geocoded to the numbers of cancer-diagnosed women within the state.

Study Medication and Dosage

Measurements of nighttime light levels, commonly referred to as ‘light at night’ (LAN), were obtained from the Defense Meteorological Satellite Program (DMSP), 1996/97 satellite images.

Outcome Measures

  1. Relative risk of breast cancer for the entire population of the state from exposure to LAN.
  2. The association between breast cancer incidence rates and potential census tract-level predictors including LAN, population density, percent non-white population, percent below poverty level, percent urban population, and the town fertility rate.
  3. The association between breast cancer and potential determinants across different age groups of women.

Key Findings

The study generated maps that color code high to low LAN levels, as well as breast cancer incidence, per census tract. As hypothesized, more cases occurred in the urban and high-population areas. Relative risk for breast cancer was 63% higher for women living in the areas with greatest light at night (LAN) compared to those women living in the lowest LAN areas (RR=1.63; 95% CI=1.41, 1.89). The association of LAN with breast cancer incidence weakened with age; the association was strongest among premenopausal women.

Practice Implications

This study is an ecological study—an observational study defined at the population or group level rather than individual level. To test whether exposure to electric LAN increases breast cancer risk in women, a measure of outdoor nighttime illumination, as detected by satellite image, was used as a surrogate for light exposure incident on the retina of women at night.

This is one of a number of similar published studies done in multiple locations around the world that suggest a correlation between artificial light at night and breast cancer risk. These findings have been consistent enough to raise the question whether simply living in an environment that is darker at night might lower breast cancer risk.

Richard Stevens, one of the authors of this current paper, first suggested that electric lighting might alter breast cancer risk in a paper he wrote in 1987.1 He theorized that exposure to LAN disrupted melatonin production and the circadian cycle. Because estrogen levels are inversely associated with melatonin, Stevens theorized that LAN would lead to greater estrogenic effects on breast tissue and eventually to higher cancer risk.2

Epidemiologists at the time knew that breast cancer rates differed markedly between Western countries and Asia. The initial assumption was that the difference was due to high-fat diets in the West. And while correlations appeared to support this ‘fat story premise,’ cohort studies had not confirmed the theory.3

Stevens’ hypothesis has been challenging to confirm as few populations remain that do not have electric lights, and those populations that do live without electricity have such dramatically different lifestyles from us that it is impossible to identify all the potential confounding influences on cancer risk.

Over the years, several key predictions have been tested and proven that confirm the initial Stevens hypothesis.

The first was that blind women, who do not tend to use indoor electric lighting, have a lower risk of BC.4

Secondly, several studies that have examined night-shift workers have found that women who work night shifts or who have more exposure to LAN regularly have higher risk of breast cancer.5-7 In a major meta-analysis of 16 prospective cohort studies published in 2015, Lin et al reported increased morbidity and all-cause mortality in breast cancer with number of years engaged in night work.8 Not all studies agree, though. Another 2016 meta-analysis out of the United Kingdom reported on 10 studies and found no association.9 These variations in results may be partially if not fully explained as due to variations in circadian genes that account for varying susceptibility to disruption.10,11

In a recently published French case-control study (975 cases and 1,317 controls), the risk for ER+ and PR+ breast cancer doubled and the risk for HER2+ cancers nearly tripled in women working night shifts.12

The idea that light at night, measured via satellite images, could be associated with breast cancer risk was first brought to our attention by a 2008 study by Itai Kloog and colleagues at the University of Haifa. They employed nighttime satellite photos taken by NASA to estimate the LAN levels in 147 communities in Israel. Breast cancer risk was affected by nighttime lighting. They found a strong positive association between LAN intensity and breast cancer rates. The breast cancer rate in communities with average night lighting was 37% higher than in communities with the lowest amount of light; and in the most well-lit communities the rate was another 27% higher. Thus they showed a 73% higher breast cancer incidence in the highest LAN-exposed communities compared to the lowest LAN-exposed communities.13

Kloog published similar findings on BC risk and LAN on a global level in 2010.14 Rybnikova confirmed these findings in 2015, finding the strongest associations between exposure to artificial light at night (ALAN) and breast cancer was in Western Europe, while in Southeast Asia and the Gulf States the effect was weaker.15

Even so, a 2015 study reported light pollution was significantly associated with breast cancer risk in both urban and rural regions of South Korea; however, no association was found between ALAN and female lung, liver, cervical, gastric, or colon cancers.16 It does appear that prostate cancer may also be strongly linked to LAN. Other cancers are much less influenced or entirely unaffected by LAN.17,18

The current Connecticut study data tell us that the communities that “are more highly lighted at night in Connecticut have higher breast cancer incidence.” Connecticut is far closer to home for most of us than Israel or South Korea, so this information in a way seems to make these other data more relevant.

Simple lifestyle changes that decrease nighttime light exposure may have clinically significant impacts on breast cancer risk. A June 2016 Israeli study reported that women who sleep with closed window shutters may reduce their BC risk by 18% (OR=0.82, 95% CI=0.68-0.99, P<0.04). Those who use a reading lamp instead of brighter indoor lighting reduce risk by 19% (OR=0.81, 95% CI=0.67-0.97, P<0.02).19

A November 2016 paper again analyzing data from Israel also reported a strong association between LAN and breast cancer and provides estimates of ‘dose effect.’ Light intensity (lux) was calculated based on road length and street lamp brightness to the degree that the authors could approximate that light intensities above 16 lux were enough to affect melatonin levels and BC morbidity.20

Why LAN increases breast cancer risk is still not fully explained. Initially, theories focused on melatonin suppression and shifts in estrogen, but more recently attention has been drawn to circadian rhythmicity and its disruption.21 Light exposure at night and melatonin disruption contributes to genetic instability.22 Circadian cycles regulate cellular responses to DNA damage and the timing of the cell cycle, though these relationships are complex and difficult to generalize as good or bad.23,24

Whatever the mechanism, light at night should be considered a potential carcinogenic environmental pollutant and we should encourage patients to reduce exposure. By doing so, we may favorably impact incidence of breast cancer in the larger population.

About the Authors

Heather Wright, ND is Vice President for the Oncology Association of Naturopathic Physicians and is the Research Director for KNOWoncology.org, a database of integrative oncology research. Dr. Wright is a regular contributor to the Natural Medicine Journal and a speaker providing continuing education to her colleagues and other medical professionals. Dr. Wright's expertise focuses on pancreatic, digestive tract, glioblastoma and breast cancer. She currently sees patients at CAMAcenter.com in Philadelphia, Pennsylvania and via telemedicine through goodapplewellness.com.

Jacob Schor ND, FABNO, is a graduate of National College of Naturopathic Medicine, Portland, Oregon, and now practices in Denver, Colorado. He served as president to the Colorado Association of Naturopathic Physicians and is on the board of directors of the Oncology Association of Naturopathic Physicians. He is recognized as a fellow by the American Board of Naturopathic Oncology. He serves on the editorial board for the International Journal of Naturopathic Medicine, Naturopathic Doctor News and Review (NDNR), and Integrative Medicine: A Clinician's Journal. In 2008, he was awarded the Vis Award by the American Association of Naturopathic Physicians. His writing appears regularly in NDNR, the Townsend Letter, and Natural Medicine Journal, where he is the Abstracts & Commentary editor.

References

  1. Stevens, RG. Review and commentary: electric power use and breast cancer: a hypothesis. Am J Epidemiol. 1987;125(4):556-561.
  2. Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 2014;64(3):207-218.
  3. Prentice RL, Kakar F, Hursting S, Sheppard L, Klein R, Kushi LH. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst. 1988;80(11):802-814.
  4. Stevens RG. Working against our endogenous circadian clock: Breast cancer and electric lighting in the modern world. Mutat Res. 2009;680(1-2):106-108.
  5. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17(1):108-111.
  6. Knutsson A, Alfredsson L, Karlsson B, et al. Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scand J Work Environ Health. 2013;39(2):170-177.
  7. Wang P, Ren FM, Lin Y, et al. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med. 2015;16(4):462-468.
  8. Lin X, Chen W, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med. 2015;16(11):1381-1387.
  9. Travis RC, Balkwill A, Fensom GK, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2016;108(12). pii: djw169.
  10. Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 2012;131(11):2547-2552.
  11. Truong T, Liquet B, Menegaux F, et al. Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer. 2014;21(4):629-638.
  12. Cordina-Duverger E, Koudou Y, Truong T, et al. Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: A population-based case-control study in France. Chronobiol Int. 2016;33(6):783-787.
  13. Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 2008;25(1):65-81.
  14. Kloog I, Stevens RG, Haim A, Portnov BA. Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control. 2010;21(12):2059-2068.
  15. Rybnikova N, Haim A, Portnov BA. Artificial light at night (ALAN) and breast cancer incidence worldwide: a revisit of earlier findings with analysis of current trends. Chronobiol Int. 2015;32(6):757-773.
  16. Kim YJ, Lee E, Lee HS, Kim M, Park MS. High prevalence of breast cancer in light polluted areas in urban and rural regions of South Korea: An ecologic study on the treatment prevalence of female cancers based on National Health Insurance data. Chronobiol Int. 2015;32(5):657-667.
  17. Kim KY, Lee E, Kim YJ, Kim J. The association between artificial light at night and prostate cancer in Gwangju City and South Jeolla Province of South Korea. Chronobiol Int. 2017;34(2):203-211.
  18. Rybnikova NA, Haim A, Portnov BA. Is prostate cancer incidence worldwide linked to artificial light at night exposures? Review of earlier findings and analysis of current trends. Arch Environ Occup Health. 2017;72(2):111-122.
  19. Keshet-Sitton A, Or-Chen K, Yitzhak S, Tzabary I, Haim A. Can avoiding light at night reduce the risk of breast cancer? Integr Cancer Ther. 2016;15(2):145-152.
  20. Keshet-Sitton A, Or-Chen K, Huber E, Haim A. Illuminating a risk for breast cancer: a preliminary ecological study on the association between streetlight and breast cancer. Integr Cancer Ther. 2016 Nov 29. pii: 1534735416678983.
  21. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008;9(10):764-775.
  22. Belancio VP. LINE-1 activity as molecular basis for genomic instability associated with light exposure at night. Mob Genet Elements. 2015;5(3):1-5.
  23. Sancar A, Lindsey-Boltz LA, Gaddameedhi S, et al. Circadian clock, cancer, and chemotherapy. Biochemistry. 2015;54(2):110-123.
  24. Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell. 2007;129(3):461-464.